ORLANDO, Fla. — Patients who underwent hip fracture surgery and were prescribed deep vein thrombosis prophylaxis for 28 days or more had a 67% lower chance of death and significantly lower ...

There is no clinically significant difference between warfarin and enoxaparin prophylaxis in terms of efficacy (venographic or clinical events) and safety for hip arthroplasty patients. There is no ...

Bristol-Myers Squibb and Pfizer announced that the FDA has accepted for review a supplemental New Drug Application (sNDA) for Eliquis (apixaban), for prophylaxis of deep vein thrombosis (DVT), which ...

Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) approved a Supplemental New Drug Application (sNDA) for Eliquis (apixaban) for the ...

Functional impairment (FI) after hematopoietic cell transplantation (HCT) and impact on quality of life (QOL). Bupropion for hot flashes control in breast cancer survivors: A prospective, double-blind ...

In total hip or total knee arthroplasty, hypercoagulability typically begins on the operating table and a hypercoagulable state persists for up to 3 months after surgery. For that reason, it is ...

Bristol-Myers Squibb Company (BMY) and Pfizer Inc. (PFE) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review a Supplemental New Drug Application (sNDA) for Eliquis ...

ThromboGenics and BioInvent Start Phase II Trial of TB-402, a Novel, Long Acting Anticoagulant for Deep Vein Thrombosis (DVT) Prophylaxis LEUVEN, Belgium and LUND, Sweden, Feb 23, 2009 (PR Newswire ...

Objective: To compare the cost effectiveness of prophylaxiswith a low-molecular-weight heparin with that of prophylaxis withunfractionated heparin for the prevention of venous thromboembolismin ...

Blood coagulation is a very complex process which has not been completely elucidated. Clot formation and fibrinolysis are in dynamic equilibrium, which prevents the patient from either bleeding or ...